Optimization of a pre-metabolization procedure using rat liver S9 and cell-extracted S9 in the Ames fluctuation test

被引:0
|
作者
Shao, Ying [1 ,2 ]
Schiwy, Andreas [3 ,4 ,5 ]
Glauch, Lisa [1 ]
Henneberger, Luise [1 ]
König, Maria [1 ]
Mühlenbrink, Marie [1 ]
Xiao, Hongxia [3 ,4 ]
Thalmann, Beat [4 ]
Schlichting, Rita [1 ]
Hollert, Henner [3 ,4 ,5 ]
Escher, Beate I. [1 ,4 ,6 ]
机构
[1] UFZ – Helmholtz Centre for Environmental Research, Department of Cell Toxicology, Permoser Str. 15, Leipzig,04318, Germany
[2] Key Laboratory of the Three Gorges Reservoir Eco-environment, Ministry of Education, Chongqing University, Shazheng street 174, Shapingba, Chongqing,400044, China
[3] Department of Ecosystem Analysis, Institute for Environmental Research, RWTH Aachen University, Worringerweg 1, Aachen,52074, Germany
[4] EWOMIS GmbH, Schießstraße 26c, Bruchköbel,63486, Germany
[5] Department of Evolutionary Ecology and Ecotoxicology, Goethe University, Max-von-Laue-Str. 13, Frankfurt/Main,60438, Germany
[6] Eberhard Karls University of Tübingen, Environmental Toxicology, Centre for Applied Geosciences, Tubingen,72074, Germany
关键词
Detoxification;
D O I
暂无
中图分类号
学科分类号
摘要
Many environmental pollutants pose a toxicological hazard only after metabolic activation. In vitro bioassays using cell lines or bacteria have often no or reduced metabolic activity, which impedes their use in the risk assessment. To improve the predictive capability of in vitro assays, external metabolization systems like the liver S9 fraction are frequently combined with in vitro toxicity assays. While it is typical for S9 fractions that samples and testing systems are combined in the same exposure system, we propose to separate the metabolism step and toxicity measurement. This allows for a modular combination of metabolic activation by enzymes isolated from rat liver (S9) or a biotechnological alternative (ewoS9R) with in vitro bioassays that lack metabolic capacity. Benzo(a)pyrene and 2-aminoanthracene were used as model compounds to optimize the conditions for the S9 metabolic degradation/activation step. The Ames assay with Salmonella typhimurium strains TA98 and TA100 was applied to validate the set-up of decoupling the S9 activation/metabolism from the bioassay system. S9 protein concentration of 0.25 mgprotein/mL, a supplement of 0.13 mM NADPH and a pre-incubation time of 100 min are recommended for activation of samples prior to dosing them to in vitro bioassays using the regular dosing protocols of the respective bioassay. EwoS9R performed equally well as Moltox S9, which is a step forward in developing true animal-free in vitro bioassays. After pre-incubation with S9 fraction, chemicals induced bacteria revertants in both the TA98 and the TA100 assay as efficiently as the standard Ames assay. The pre-incubation of chemicals with S9 fraction could serve for a wide range of cellular in vitro assays to efficiently combine activation and toxicity measurement, which may greatly facilitate the application of these assays for chemical hazard assessment and monitoring of environmental samples. © 2020 Elsevier B.V.
引用
收藏
相关论文
共 50 条
  • [1] Optimization of a pre-metabolization procedure using rat liver S9 and cell-extracted S9 in the Ames fluctuation test
    Shao, Ying
    Schiwy, Andreas
    Glauch, Lisa
    Henneberger, Luise
    Koenig, Maria
    Muhlenbrink, Marie
    Xiao, Hongxia
    Thalmann, Beat
    Schlichting, Rita
    Hollert, Henner
    Escher, Beate I.
    SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 749
  • [2] Advantage of the use of human liver S9 in the Ames test
    Hakura, A
    Suzuki, S
    Satoh, T
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1999, 438 (01) : 29 - 36
  • [3] An improvement of the Ames test using a modified human liver S9 preparation
    Hakura, A
    Suzuki, S
    Sawada, S
    Motooka, S
    Satoh, T
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2001, 46 (03) : 169 - 172
  • [4] REASONS FOR OPTIMAL LEVELS OF S9 FRACTION IN AMES TEST AND FLUCTUATION TESTS
    GREEN, MHL
    FORSTER, R
    PRIESTLEY, A
    GENETICS, 1979, 91 (04) : S42 - S42
  • [5] AN EXPLANATION FOR OPTIMAL LEVELS OF S9 IN AMES AND FLUCTUATION TESTS
    FORSTER, R
    GREEN, MHL
    PRIESTLEY, A
    MUTATION RESEARCH, 1981, 85 (04): : 264 - 264
  • [6] Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors
    Hakura, A
    Suzuki, S
    Sawada, S
    Sugihara, T
    Hori, YJ
    Uchida, K
    Kerns, WD
    Sagami, F
    Motooka, S
    Satoh, T
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2003, 37 (01) : 20 - 27
  • [7] BEEF EXTRACT MUTAGENS, AND NOT LIVER S9, INCREASE MUTATION FREQUENCY IN THE AMES TEST
    DOLARA, P
    MUTATION RESEARCH, 1982, 104 (06): : 345 - 346
  • [8] Evaluation of 4-methylimidazole, in the Ames/Salmonella test using induced rodent liver and lung S9
    Beevers, Carol
    Adamson, Richard H.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2016, 57 (01) : 51 - 57
  • [9] AROCLOR-INDUCED AND UNINDUCED S9 WORK DIFFERENTLY IN THE AMES AND FLUCTUATION TESTS
    FORSTER, R
    GREEN, MML
    PRIESTLEY, A
    MUTATION RESEARCH, 1980, 74 (03): : 252 - 253
  • [10] STUDIES OF THE METABOLIZING EFFECT OF THE S9 LIVER FRACTION, HEPATIC MICROSOMES AND MICROSOMAL SUPERNATANT IN THE AMES TEST
    ARNI, P
    LUTH, A
    DEPARADE, E
    MULLER, D
    MUTATION RESEARCH, 1980, 74 (02): : 154 - 154